What is PatchMD?
PatchMD operates at the intersection of health technology and consumer wellness, specializing in transdermal vitamin patches. By bypassing the digestive system, the company provides a sophisticated alternative to traditional oral supplements, addressing the needs of consumers with dietary restrictions or those who experience difficulty with pill consumption. Their product portfolio, which includes solutions for sleep support, weight management, and bariatric nutrition, is underpinned by doctor-recommended formulations. This focus on bioavailability and convenience has established PatchMD as a notable player in the personalized health space, effectively simplifying the daily regimen for a diverse demographic of health-conscious individuals.
How much funding has PatchMD raised?
PatchMD has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PatchMD
PPP
Public-Private Partnership
What's next for PatchMD?
Following this late-stage financing, PatchMD is expected to prioritize the expansion of its distribution channels and the acceleration of its research and development pipeline. The strategic deployment of this capital will likely focus on enhancing manufacturing capabilities to meet rising demand while exploring new therapeutic applications for transdermal delivery. As the company matures, the focus will shift toward solidifying its market share and potentially exploring international markets where the demand for innovative, non-invasive wellness solutions is rapidly increasing. By leveraging its current momentum, PatchMD is poised to redefine standards in the supplement industry through continued clinical validation and product diversification.
See full PatchMD company page
